New COPD drug candidate tested for safety in healthy volunteers
Knowledge-focused
Completed
This early-stage trial tested the safety of Hemay005 tablets in 468 healthy Chinese adults. Researchers compared different ways of giving the drug (gradually increasing the dose vs. fixed dose) to see which caused fewer side effects. The goal was to gather safety information befo…
Phase: PHASE1 • Sponsor: Anhui Hemay Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated May 18, 2026 12:10 UTC